Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women
Launched by I.R.C.C.S OSPEDALE GALEAZZI-SANT'AMBROGIO · Dec 21, 2017
Trial Information
Current as of August 30, 2025
Unknown status
Keywords
ClinConnect Summary
A grave change associated with human ageing is progressive decline in skeletal muscle mass, a downward spiral that may lead to decreased strength and functionality. The term 'sarcopenia' (Greek 'sarx' or flesh + 'penia' or loss) has been proposed to describe this age-related decrease of muscle mass. Sarcopenia represents an impaired state of health with increased risk of falls and fractures, impaired ability to perform activities of daily living, and loss of independence. The imaging technologies used to detect loss of skeletal muscle mass in sarcopenia include: dual X-ray absorptiometry (D...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female.
- • Aged over 60 yo.
- • Classified as osteoporotic with t-score = or \< -2,5 evaluated by DXA.
- • Autonomous walking.
- • Signed informed consent.
- Exclusion Criteria:
- • Male.
- • Aged under 60 yo.
- • Psychiatric disorders.
- • Neurological pathologies.
- • Endocrine disorders.
- • Active cigarettes smoke.
- • Recent bone fractures (6 months)
- • Surgical treatments for orthopedic pathologies (6 months).
- • Pacemaker carrier.
- • Use of drugs influencing bone metabolism or limiting physical function.
About I.R.C.C.S Ospedale Galeazzi Sant'ambrogio
The I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio is a leading clinical research institute and hospital in Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As a designated Institute of Hospitalization and Care of Scientific Relevance (I.R.C.C.S.), it focuses on translational research that bridges the gap between laboratory findings and clinical applications. The facility is equipped with state-of-the-art technology and a multidisciplinary team of experts, enabling it to conduct a wide range of clinical trials aimed at improving treatment outcomes across various medical fields. Its dedication to ethical practices and patient safety ensures that all research activities align with the highest international standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials